IP Library Granted Patent US 8,138,322
Granted Patent B2
US 8,138,322 · App. 12/177,925 · Granted Mar 20, 2012

Human T1R2 nucleic acid sequences and polypeptides

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,138,322
App. No.
12/177,925
Granted
Mar 20, 2012
Kind
B2
Abstract

Binding assays for identifying compounds that modulate human T1R2 polypeptide associated taste are disclosed. These assays detect the specific binding of compounds to a human T1R2 polypeptide or the modulation of the specific binding of a compound that specifically binds to a human T1R2 polypeptide. The binding assays may include the use of detectable labels, e.g., radionuclides, enzymes, fluorophases, and the like. Compounds identified in these binding assays have putative application as T1R2 taste modulators, particularly sweet taste, and potentially are useful additives in compositions for human or animal consumption.

Claims (13)

1. An isolated nucleic acid that encodes a T1R2 taste receptor polypeptide or T1R2 extracellular or T1R2 cytoplasmic domain wherein said nucleic acid is selected from the group consisting of (i) the nucleic acid of SEQ ID NO 23; (ii) a nucleic acid encoding a polypeptide having at least 90% sequence identity to the T1R2 polypeptide in SEQ ID NO:21 or an extracellular or cytoplasmic domain thereof; (iii) a nucleic acid s encoding a human T1R2 polypeptide or a T1R2 cytoplasmic or extracellular domain wherein said nucleic acid hybridizes under stringent hybridization conditions to the complement of the nucleic acid sequence contained in SEQ ID NO: 23 and wherein said stringent hybridization conditions are hybridization in 50% formamide, 5 times SSC and 1% SDS, incubating at 42 degrees C., with wash in 0.2 times SSC and 0.1% SDS at 65 degrees C., wherein the hybridization and wash steps are each carried out for at least 1 minute.

2. The isolated nucleic acid of claim 1 wherein said nucleic acid encodes a cytoplasmic or extracellular domain of the T1R2 polypeptide of SEQ ID NO: 21.

3. An isolated RNA molecule transcribed from the isolated nucleic acid of claim 1 .

4. The isolated nucleic acid of claim 1 or 2 which further comprises a sequence encoding another GPCR or a fragment thereof.

5. The isolated nucleic acid of claim 4 wherein said GPCR is another T1R.

6. The isolated nucleic acid of claim 4 wherein said GPCR is not a T1R.

7. The isolated nucleic acid of claim 1 or 2 which is operably linked to a promoter.

8. A recombinant cell which expresses an isolated nucleic acid e according to claim 1 .

9. The recombinant cell of claim 8 which is selected from a human, amphibian, insect, and yeast cell.

10. The recombinant cell of claim 9 which expresses a G protein.

11. The isolated nucleic acid of claim 1 , which further comprises a heterologous coding sequence that facilitates the expression of the T1R2 polypeptide on the surface of a cell that expresses the isolated nucleic acid sequence.

12. The isolated nucleic acid of claim 11 , wherein said heterologous coding sequence encodes a mammalian rhodopsin polypeptide.

13. The isolated nucleic acid molecule of claim 1 which further comprises a heterologous coding sequence encoding green fluorescent protein or another detectable marker gene.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 23, 2019
From: ADLER, JON ELLIOT; LI, XIAODONG; STASZEWSKI, LENA; O'CONNELL, SHAWN; ZOZULYA, SERGEY
To: SENOMYX, INC.
Reel/Frame 050805/0474 →
MERGER Recorded Oct 23, 2019
From: SENOMYX, INC.
To: FIRMENICH INCORPORATED
Reel/Frame 050805/0594 →